Modular DNA Logic Gates for Multi-Biomarker Fluorescence Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing DNA logic gates for cancer diagnosis are complex, have high error rates, and require laborious sequence design, especially when detecting multiple biomarker inputs, and they often rely on invasive methods like biopsies.
Innovation Solution
Development of modular DNA logic gates, including OR, NAND, and IMPLY gates, that integrate multiple YES and/or NOT units in parallel, using a DNA scaffold structure with hybridization boards, and molecular beacon probes for fluorescence detection, eliminating strand displacement and diffusion errors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If DNA logic gates use serial strand displacement mechanism, then they can achieve logic function, but they have high error rates and require laborious sequence design
Solution Approach 1:
The patent divides the DNA logic gate into modular components: input strands, output strands, and gateway structures. Each module performs a specific function (input binding, output generation, or signal relay), allowing independent design and assembly. This segmentation reduces overall design complexity while maintaining high reliability through standardized modular interfaces.
Solution Approach 2:
The patent introduces gateway structures as intermediary elements that mediate between input and output strands. These gateways act as controlled communication channels, enabling reliable signal transmission without requiring complex direct strand displacement pathways. The gateway simplifies the interaction mechanism and reduces error rates.
2Adaptability or versatility
If DNA logic gates detect multiple biomarkers, then they improve diagnostic capability, but they increase sequence design complexity and manufacturing difficulty
Solution Approach 1:
The patent designs universal gateway structures and modular logic units that can detect multiple different biomarkers through a common architectural framework. The same basic module type can be configured for different biomarkers by changing input strand sequences, while maintaining identical manufacturing and assembly procedures. This universality enables multi-biomarker detection without proportionally increasing manufacturing complexity.
Solution Approach 2:
By segmenting the detection system into reusable modular units (input binding modules, output modules, gateway modules), the patent enables detection of multiple biomarkers through combinatorial assembly of standard parts. Each module can be independently manufactured and then assembled, simplifying the overall manufacturing process compared to designing custom gates for each biomarker pair.
3Measurement precision
If DNA logic gates use invasive biopsy methods, then they can detect cancer biomarkers, but they reduce patient comfort and increase procedural complexity
Solution Approach 1:
The patent replaces mechanical tissue biopsy procedures with a molecular detection system that analyzes biomarkers in body fluids (blood, urine). The DNA logic gate performs computational analysis on molecular inputs, substituting the mechanical invasion of biopsy with a non-invasive fluid-based sampling approach, thereby maintaining detection accuracy while significantly improving patient comfort.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These gates provide accurate, high-throughput, and cost-effective detection of multiple biomarkers, enabling early cancer diagnosis with minimal invasiveness and reduced manufacturing complexity.
Implementation Method 1
molecular beacon probes for fluorescence detection
Implementation Method 2
DNA scaffold structure with hybridization boards
Data Source
AI summary
Herein, based on Boolean operators, DNA logic gate complexes are constructed to obtain True (fluorescence signal recovery) or False (fluorescence signal quenching) value using a molecular beacon acting as output. A DNA logic gate complex is composed of a DNA board and at least two modular logic units of YES and/or NOT gate. First, the DNA board is designed to accommodate individual YES and/or NOT modular logic units. An OR logic gate is composed of the DNA board and at least two YES modular logic units, and when there are multiple YES modular logic units, they are arranged in a parallel manner. A NAND logic gate is composed of a DNA board and at least two NOT modular logic units, and when there are multiple NOT modular logic units, they are arranged in a parallel manner. An IMPLY logic gate comprises at least one YES modular logic unit and at least one NOT modular logic unit as well as the DNA board. The designed DNA logic gate complexes were tested with biomarker miRNAs of hepatocellular carcinoma and successfully computed True/False fluorescence outcomes, exhibiting great potential for applications in the field of diseases diagnosis.